Quantitative sensory testing demonstrates that subclinical sensory neuropathy is prevalent in patients with cancer

Richard B. Lipton, B. S. Galer, J. P. Dutcher, R. K. Portenoy, A. Berger, Joseph C. Arezzo, M. Mizruchi, P. H. Wiernik, H. H. Schaumburg

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Vibration threshold (VT) determinations were used to assess the function of the large nerve-fiber sensory system in 171 patients with cancer and 58 healthy subjects. Significant differences in VT indicate dysfunction of this sensory system in the cancer group. Twelve percent of the cancer patients had elevated VT compared with 1.7% of control subjects. Elevated VT was not associated with risk factors for neuropathy such as diabetes, renal disease, poor nutrition, or treatment with chemotherapy. Although VT elevation was associated with alcoholism and increasing age, these variables accounted for only a small proportion of the variance in VT. These data suggest that VT determinations are a useful method for quantifying sensory abnormalities in cancer patients. Sensory abnormalities occur in a significant proportion of patients with cancer and seem to be related directly to the neoplasm, rather than to known risk factors for neuropathy.

Original languageEnglish (US)
Pages (from-to)944-946
Number of pages3
JournalArchives of Neurology
Volume44
Issue number9
StatePublished - 1987

Fingerprint

Vibration
Neoplasms
Cancer
Testing
Nerve Fibers
Alcoholism
Healthy Volunteers
Kidney
Drug Therapy

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Lipton, R. B., Galer, B. S., Dutcher, J. P., Portenoy, R. K., Berger, A., Arezzo, J. C., ... Schaumburg, H. H. (1987). Quantitative sensory testing demonstrates that subclinical sensory neuropathy is prevalent in patients with cancer. Archives of Neurology, 44(9), 944-946.

Quantitative sensory testing demonstrates that subclinical sensory neuropathy is prevalent in patients with cancer. / Lipton, Richard B.; Galer, B. S.; Dutcher, J. P.; Portenoy, R. K.; Berger, A.; Arezzo, Joseph C.; Mizruchi, M.; Wiernik, P. H.; Schaumburg, H. H.

In: Archives of Neurology, Vol. 44, No. 9, 1987, p. 944-946.

Research output: Contribution to journalArticle

Lipton, RB, Galer, BS, Dutcher, JP, Portenoy, RK, Berger, A, Arezzo, JC, Mizruchi, M, Wiernik, PH & Schaumburg, HH 1987, 'Quantitative sensory testing demonstrates that subclinical sensory neuropathy is prevalent in patients with cancer', Archives of Neurology, vol. 44, no. 9, pp. 944-946.
Lipton, Richard B. ; Galer, B. S. ; Dutcher, J. P. ; Portenoy, R. K. ; Berger, A. ; Arezzo, Joseph C. ; Mizruchi, M. ; Wiernik, P. H. ; Schaumburg, H. H. / Quantitative sensory testing demonstrates that subclinical sensory neuropathy is prevalent in patients with cancer. In: Archives of Neurology. 1987 ; Vol. 44, No. 9. pp. 944-946.
@article{372459b959324014afe711fbabd6e0f4,
title = "Quantitative sensory testing demonstrates that subclinical sensory neuropathy is prevalent in patients with cancer",
abstract = "Vibration threshold (VT) determinations were used to assess the function of the large nerve-fiber sensory system in 171 patients with cancer and 58 healthy subjects. Significant differences in VT indicate dysfunction of this sensory system in the cancer group. Twelve percent of the cancer patients had elevated VT compared with 1.7{\%} of control subjects. Elevated VT was not associated with risk factors for neuropathy such as diabetes, renal disease, poor nutrition, or treatment with chemotherapy. Although VT elevation was associated with alcoholism and increasing age, these variables accounted for only a small proportion of the variance in VT. These data suggest that VT determinations are a useful method for quantifying sensory abnormalities in cancer patients. Sensory abnormalities occur in a significant proportion of patients with cancer and seem to be related directly to the neoplasm, rather than to known risk factors for neuropathy.",
author = "Lipton, {Richard B.} and Galer, {B. S.} and Dutcher, {J. P.} and Portenoy, {R. K.} and A. Berger and Arezzo, {Joseph C.} and M. Mizruchi and Wiernik, {P. H.} and Schaumburg, {H. H.}",
year = "1987",
language = "English (US)",
volume = "44",
pages = "944--946",
journal = "Archives of Neurology",
issn = "0003-9942",
publisher = "American Medical Association",
number = "9",

}

TY - JOUR

T1 - Quantitative sensory testing demonstrates that subclinical sensory neuropathy is prevalent in patients with cancer

AU - Lipton, Richard B.

AU - Galer, B. S.

AU - Dutcher, J. P.

AU - Portenoy, R. K.

AU - Berger, A.

AU - Arezzo, Joseph C.

AU - Mizruchi, M.

AU - Wiernik, P. H.

AU - Schaumburg, H. H.

PY - 1987

Y1 - 1987

N2 - Vibration threshold (VT) determinations were used to assess the function of the large nerve-fiber sensory system in 171 patients with cancer and 58 healthy subjects. Significant differences in VT indicate dysfunction of this sensory system in the cancer group. Twelve percent of the cancer patients had elevated VT compared with 1.7% of control subjects. Elevated VT was not associated with risk factors for neuropathy such as diabetes, renal disease, poor nutrition, or treatment with chemotherapy. Although VT elevation was associated with alcoholism and increasing age, these variables accounted for only a small proportion of the variance in VT. These data suggest that VT determinations are a useful method for quantifying sensory abnormalities in cancer patients. Sensory abnormalities occur in a significant proportion of patients with cancer and seem to be related directly to the neoplasm, rather than to known risk factors for neuropathy.

AB - Vibration threshold (VT) determinations were used to assess the function of the large nerve-fiber sensory system in 171 patients with cancer and 58 healthy subjects. Significant differences in VT indicate dysfunction of this sensory system in the cancer group. Twelve percent of the cancer patients had elevated VT compared with 1.7% of control subjects. Elevated VT was not associated with risk factors for neuropathy such as diabetes, renal disease, poor nutrition, or treatment with chemotherapy. Although VT elevation was associated with alcoholism and increasing age, these variables accounted for only a small proportion of the variance in VT. These data suggest that VT determinations are a useful method for quantifying sensory abnormalities in cancer patients. Sensory abnormalities occur in a significant proportion of patients with cancer and seem to be related directly to the neoplasm, rather than to known risk factors for neuropathy.

UR - http://www.scopus.com/inward/record.url?scp=0023180942&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023180942&partnerID=8YFLogxK

M3 - Article

C2 - 3039951

AN - SCOPUS:0023180942

VL - 44

SP - 944

EP - 946

JO - Archives of Neurology

JF - Archives of Neurology

SN - 0003-9942

IS - 9

ER -